108 related articles for article (PubMed ID: 26460004)
1. Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals.
Zhu HH; Luo X; Zhang K; Cui J; Zhao H; Ji Z; Zhou Z; Yao J; Zeng L; Ji K; Gao WQ; Zhang ZY; Feng GS
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13342-7. PubMed ID: 26460004
[TBL] [Abstract][Full Text] [Related]
2. Treating leukemia at the risk of inducing severe anemia.
Chen WS; Zhu HH; Feng GS
Exp Hematol; 2016 May; 44(5):329-31. PubMed ID: 26826310
[TBL] [Abstract][Full Text] [Related]
3. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.
Luo X; Liao R; Hanley KL; Zhu HH; Malo KN; Hernandez C; Wei X; Varki NM; Alderson N; Chu C; Li S; Fan J; Loomba R; Qiu SJ; Feng GS
Cell Rep; 2016 Dec; 17(11):2979-2993. PubMed ID: 27974211
[TBL] [Abstract][Full Text] [Related]
4. Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ.
Chen CL; Chiang TH; Tseng PC; Wang YC; Lin CF
Biochem Biophys Res Commun; 2015 Oct; 466(3):578-84. PubMed ID: 26385178
[TBL] [Abstract][Full Text] [Related]
5. Role of SHP2 in hematopoiesis and leukemogenesis.
Pandey R; Saxena M; Kapur R
Curr Opin Hematol; 2017 Jul; 24(4):307-313. PubMed ID: 28306669
[TBL] [Abstract][Full Text] [Related]
6. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
[TBL] [Abstract][Full Text] [Related]
7. Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase.
He Z; Zhu HH; Bauler TJ; Wang J; Ciaraldi T; Alderson N; Li S; Raquil MA; Ji K; Wang S; Shao J; Henry RR; King PD; Feng GS
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E79-88. PubMed ID: 23236157
[TBL] [Abstract][Full Text] [Related]
8. Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis.
Li S; Hsu DD; Wang H; Feng GS
Front Med; 2012 Sep; 6(3):275-9. PubMed ID: 22869052
[TBL] [Abstract][Full Text] [Related]
9. Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor.
Mathew G; Hannan A; Hertzler-Schaefer K; Wang F; Feng GS; Zhong J; Zhao JJ; Downward J; Zhang X
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13156-13161. PubMed ID: 27799550
[TBL] [Abstract][Full Text] [Related]
10. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
[TBL] [Abstract][Full Text] [Related]
11. The transition from stem cell to progenitor spermatogonia and male fertility requires the SHP2 protein tyrosine phosphatase.
Puri P; Phillips BT; Suzuki H; Orwig KE; Rajkovic A; Lapinski PE; King PD; Feng GS; Walker WH
Stem Cells; 2014 Mar; 32(3):741-53. PubMed ID: 24123360
[TBL] [Abstract][Full Text] [Related]
12. Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.
Pan Y; Carbe C; Powers A; Feng GS; Zhang X
Development; 2010 Apr; 137(7):1085-93. PubMed ID: 20215346
[TBL] [Abstract][Full Text] [Related]
13. Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2.
Yu J; Deng R; Zhu HH; Zhang SS; Zhu C; Montminy M; Davis R; Feng GS
J Biol Chem; 2013 Feb; 288(6):3823-30. PubMed ID: 23269672
[TBL] [Abstract][Full Text] [Related]
14. Functions of Shp2 in cancer.
Zhang J; Zhang F; Niu R
J Cell Mol Med; 2015 Sep; 19(9):2075-83. PubMed ID: 26088100
[TBL] [Abstract][Full Text] [Related]
15. SHP2 sails from physiology to pathology.
Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine phosphatase Shp2 acts downstream of GDNF/Ret in branching morphogenesis of the developing mouse kidney.
Willecke R; Heuberger J; Grossmann K; Michos O; Schmidt-Ott K; Walentin K; Costantini F; Birchmeier W
Dev Biol; 2011 Dec; 360(2):310-7. PubMed ID: 22015719
[TBL] [Abstract][Full Text] [Related]
17. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T
Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110
[TBL] [Abstract][Full Text] [Related]
18. [The role of protein tyrosine phosphatases Shp-2 involved in the formation of the neuromuscular junction].
Zhao XT; Zhang Z
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1052-6. PubMed ID: 16784710
[TBL] [Abstract][Full Text] [Related]
19. Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling.
Noda S; Takahashi A; Hayashi T; Tanuma S; Hatakeyama M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1133-9. PubMed ID: 26742426
[TBL] [Abstract][Full Text] [Related]
20. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
